The company's Scientific Advisory Board consists of leading medical, clinical and industry professionals and academic experts that will advise the company on medical, clinical, industry and strategic direction. The initial members of the Scientific Advisory Board are listed below. Additional members will be added in the future.
Renu Virmani, MD.
Dr. Renu Virmani currently serves as medical director of CVPath, International Registry of Pathology in Gaithersburg, Maryland. She is recognized as one of the leaders in the search for diagnostic and treatment therapies for vulnerable plaque. Dr. Virmani is also clinical professor in the Department of Pathology at: Georgetown University; University of Maryland, Baltimore; Uniform University of Health Sciences; and Vanderbilt University.
Steven R. Bailey, MD.
Dr. Steven R. Bailey is professor of medicine and radiology in the School of Medicine at the University of Texas Health Science Center at San Antonio, where he is also chief of the Janey and Dolph Briscoe Division of Cardiology, and currently serves as president of the Society for Cardiovascular Angiography and Interventions.
Mark Jenkins, MD.
Dr. Mark Jenkins is an interventional cardiologist in Dallas, Texas; he is a previous fellow of Johns Hopkins School of Medicine where he conducted research on the stent program.
Barry T. Katzen, MD.
Dr. Barry Katzen is founder and medical director of Baptist Cardiac & Vascular Institute in Miami, Florida. He is a fellow in the American College of Cardiology, the American College of Radiology, and the Society of Cardiovascular and Interventional Radiology -- of which he is a past president -- and is also a clinical professor of radiology at the University of Miami School of Medicine.
Peter Fitzgerald, MD.
Dr. Peter Fitzgerald is director of both the Center for Cardiovascular Technology and the Cardiovascular Core Analysis Laboratory at Stanford University Medical School. He is an interventional cardiologist with a doctorate in engineering. He also is a professor in both the departments of medicine and engineering at Stanford.
Robert Bersin, MD.
Dr. Robert Bersin is director of endovascular services at Seattle Cardiology in Seattle, Washington. He is a fellow of American College of Cardiology, American College of Physicians, and the American Society for Cardiac Interventionists, as well as a member of the International Society for Endovascular Surgery.
Frank J. Criado, MD.
Dr. Frank J. Criado is a board-certified vascular surgeon. He is a founding member and current secretary of the International Society of Endovascular Specialists (ISES), a fellow of the American College of Surgeons (FACS), and a member of all major U.S. and international vascular societies. Dr. Criado is a vascular surgeon and interventionist at Union Memorial Hospital in Baltimore, Maryland, where he established the endovascular program in 1988.
Jose Antonio Condado, MD.
Dr. Jose Antonio Condado is a doctor of cardiology at Trinity Medical Center, Caracas, Venezuela.
Robert S. Schwartz, MD.
Dr. Robert S. Schwartz is a professor of medicine at University of Minnesota Medical School, medical director at the Minnesota Cardiovascular Research Institute, and cardiologist at the Minneapolis Heart Institute. His clinical and research interests include interventional cardiology, imaging, clinical information processing and clinical medical care.